Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

BGM Select Opportunities Fund shows strong year with 16.15% gains YTD (+2.01% in September)

Tuesday, October 22, 2013

Komfie Manalo, Opalesque Asia:

The Bahamas-based Magnum BGM Select Opportunities Fund posted strong gains this year with a year-to-date gross return of 16.5% (+2.01% in September, according to its latest report to investors.

"September was another strong month for the fund," BGM said in the report. It added, "We saw strength across our equity portfolio, with gains by Visa and Radian. On the fixed income portfolio, our Investec Finance, Old Mutual PLC and Skipton bonds generated a positive contribution."

The strong returns generated by their portfolios boosted the hedge fund’s long term prognosis, it said.

"We continued to sit with more than half the fund in cash. We have de‐risked considerably as a result, but do not intend to sit with this much cash for too long. We have identified a number of interesting investment opportunities and are slowly starting to build up our positions. Given the current uncertainty in Washington, our focus on identifying sound investment opportunities seems more appropriate than ever," the report said.

BGM has been a consistent positive performer this year except in the months of June and August when it registered losses of -1.87% and -0.50% respectively.

The fund closed 2012 up 28.24% and started this year with a 1.52% gain in January. BGM Select ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its